Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Irene González-Domínguez

University Name

United States

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

100%

Virology

100%

Sars-cov-2

50%

Vaccinology

50%

Vaccine Development

50%

Immune Response

30%

Influenza Research

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

FPU

Open Date: 2017-09-01

Close Date: 2020-07-01

Articles18

The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex

Article Link

Year:

2024

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice

Article Link

Year:

2024

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach

Article Link

Year:

2024

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.

Article Link

Year:

2023

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

Article Link

Year:

2023

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice

Article Link

Year:

2023

Bioprocess characterization of virus‐like particle production with the insect cell baculovirus expression system at nanoparticle level

Article Link

Year:

2022

Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines

Article Link

Year:

2022

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.

Article Link

Year:

2022

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.

Article Link

Year:

2022

Transduction of HEK293 Cells with BacMam Baculovirus Is an Efficient System for the Production of HIV-1 Virus-like Particles.

Article Link

Year:

2022

Micrometric DNA/PEI polyplexes correlate with higher transient gene expression yields in HEK 293 cells.

Article Link

Year:

2022

Bioprocess characterization of virus-like particle production with the insect cell baculovirus expression system at nanoparticle level

Article Link

Year:

2022

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Article Link

Year:

2022

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.

Article Link

Year:

2021

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

Article Link

Year:

2021

A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles

Article Link

Year:

2021

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice

Article Link

Year:

2021

Collaborators5

Weina Sun

Icahn School of Medicine at Mount Sinai

UNITED STATES

Amine Kamen

Professor

McGill University Faculty of Engineering

CANADA

gerald striedner

University Professor

University of Natural Resources and Life Sciences Vienna

AUSTRIA

Lynda Coughlan

Assistant Professor

University of Maryland School of Medicine

UNITED STATES

Juan Manuel Carreno Quiroz

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

How do I reach out?

Meet Kite AI